Global Dihydroartemisinin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Dihydroartemisinin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Dihydroartemisinin industry chain, the market status of Malaria Treatment (Pharmaceutical Grade, Industrial Grade), Scientific Research (Pharmaceutical Grade, Industrial Grade), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dihydroartemisinin.
Regionally, the report analyzes the Dihydroartemisinin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dihydroartemisinin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dihydroartemisinin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dihydroartemisinin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Pharmaceutical Grade, Industrial Grade).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dihydroartemisinin market.
Regional Analysis: The report involves examining the Dihydroartemisinin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dihydroartemisinin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dihydroartemisinin:
Company Analysis: Report covers individual Dihydroartemisinin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dihydroartemisinin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Malaria Treatment, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Dihydroartemisinin. It assesses the current state, advancements, and potential future developments in Dihydroartemisinin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dihydroartemisinin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dihydroartemisinin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Dihydroartemisinin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dihydroartemisinin, with price, sales, revenue and global market share of Dihydroartemisinin from 2019 to 2024.
Chapter 3, the Dihydroartemisinin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dihydroartemisinin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Dihydroartemisinin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dihydroartemisinin.
Chapter 14 and 15, to describe Dihydroartemisinin sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Dihydroartemisinin industry chain, the market status of Malaria Treatment (Pharmaceutical Grade, Industrial Grade), Scientific Research (Pharmaceutical Grade, Industrial Grade), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dihydroartemisinin.
Regionally, the report analyzes the Dihydroartemisinin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dihydroartemisinin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dihydroartemisinin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dihydroartemisinin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Pharmaceutical Grade, Industrial Grade).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dihydroartemisinin market.
Regional Analysis: The report involves examining the Dihydroartemisinin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dihydroartemisinin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dihydroartemisinin:
Company Analysis: Report covers individual Dihydroartemisinin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dihydroartemisinin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Malaria Treatment, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to Dihydroartemisinin. It assesses the current state, advancements, and potential future developments in Dihydroartemisinin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dihydroartemisinin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dihydroartemisinin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Pharmaceutical Grade
- Industrial Grade
- Malaria Treatment
- Scientific Research
- Others
- Sanofi
- KPC Pharmaceuticals
- Guangxi Xiancaotang Pharmaceutical
- Guilin Pharmaceutical
- Kerui Nanhai Pharmaceutical
- Shanghai Natural Bio-engineering Co
- Novanat Bioresource
- Botanical Extracts EPZ Ltd
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Dihydroartemisinin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dihydroartemisinin, with price, sales, revenue and global market share of Dihydroartemisinin from 2019 to 2024.
Chapter 3, the Dihydroartemisinin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dihydroartemisinin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Dihydroartemisinin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dihydroartemisinin.
Chapter 14 and 15, to describe Dihydroartemisinin sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Dihydroartemisinin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dihydroartemisinin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pharmaceutical Grade
1.3.3 Industrial Grade
1.4 Market Analysis by Application
1.4.1 Overview: Global Dihydroartemisinin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Malaria Treatment
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Dihydroartemisinin Market Size & Forecast
1.5.1 Global Dihydroartemisinin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Dihydroartemisinin Sales Quantity (2019-2030)
1.5.3 Global Dihydroartemisinin Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dihydroartemisinin Product and Services
2.1.4 Sanofi Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 KPC Pharmaceuticals
2.2.1 KPC Pharmaceuticals Details
2.2.2 KPC Pharmaceuticals Major Business
2.2.3 KPC Pharmaceuticals Dihydroartemisinin Product and Services
2.2.4 KPC Pharmaceuticals Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 KPC Pharmaceuticals Recent Developments/Updates
2.3 Guangxi Xiancaotang Pharmaceutical
2.3.1 Guangxi Xiancaotang Pharmaceutical Details
2.3.2 Guangxi Xiancaotang Pharmaceutical Major Business
2.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product and Services
2.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
2.4 Guilin Pharmaceutical
2.4.1 Guilin Pharmaceutical Details
2.4.2 Guilin Pharmaceutical Major Business
2.4.3 Guilin Pharmaceutical Dihydroartemisinin Product and Services
2.4.4 Guilin Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Guilin Pharmaceutical Recent Developments/Updates
2.5 Kerui Nanhai Pharmaceutical
2.5.1 Kerui Nanhai Pharmaceutical Details
2.5.2 Kerui Nanhai Pharmaceutical Major Business
2.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product and Services
2.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates
2.6 Shanghai Natural Bio-engineering Co
2.6.1 Shanghai Natural Bio-engineering Co Details
2.6.2 Shanghai Natural Bio-engineering Co Major Business
2.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product and Services
2.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Shanghai Natural Bio-engineering Co Recent Developments/Updates
2.7 Novanat Bioresource
2.7.1 Novanat Bioresource Details
2.7.2 Novanat Bioresource Major Business
2.7.3 Novanat Bioresource Dihydroartemisinin Product and Services
2.7.4 Novanat Bioresource Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novanat Bioresource Recent Developments/Updates
2.8 Botanical Extracts EPZ Ltd
2.8.1 Botanical Extracts EPZ Ltd Details
2.8.2 Botanical Extracts EPZ Ltd Major Business
2.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Product and Services
2.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Botanical Extracts EPZ Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DIHYDROARTEMISININ BY MANUFACTURER
3.1 Global Dihydroartemisinin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Dihydroartemisinin Revenue by Manufacturer (2019-2024)
3.3 Global Dihydroartemisinin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Dihydroartemisinin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Dihydroartemisinin Manufacturer Market Share in 2023
3.4.2 Top 6 Dihydroartemisinin Manufacturer Market Share in 2023
3.5 Dihydroartemisinin Market: Overall Company Footprint Analysis
3.5.1 Dihydroartemisinin Market: Region Footprint
3.5.2 Dihydroartemisinin Market: Company Product Type Footprint
3.5.3 Dihydroartemisinin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dihydroartemisinin Market Size by Region
4.1.1 Global Dihydroartemisinin Sales Quantity by Region (2019-2030)
4.1.2 Global Dihydroartemisinin Consumption Value by Region (2019-2030)
4.1.3 Global Dihydroartemisinin Average Price by Region (2019-2030)
4.2 North America Dihydroartemisinin Consumption Value (2019-2030)
4.3 Europe Dihydroartemisinin Consumption Value (2019-2030)
4.4 Asia-Pacific Dihydroartemisinin Consumption Value (2019-2030)
4.5 South America Dihydroartemisinin Consumption Value (2019-2030)
4.6 Middle East and Africa Dihydroartemisinin Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Dihydroartemisinin Sales Quantity by Type (2019-2030)
5.2 Global Dihydroartemisinin Consumption Value by Type (2019-2030)
5.3 Global Dihydroartemisinin Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dihydroartemisinin Sales Quantity by Application (2019-2030)
6.2 Global Dihydroartemisinin Consumption Value by Application (2019-2030)
6.3 Global Dihydroartemisinin Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Dihydroartemisinin Sales Quantity by Type (2019-2030)
7.2 North America Dihydroartemisinin Sales Quantity by Application (2019-2030)
7.3 North America Dihydroartemisinin Market Size by Country
7.3.1 North America Dihydroartemisinin Sales Quantity by Country (2019-2030)
7.3.2 North America Dihydroartemisinin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Dihydroartemisinin Sales Quantity by Type (2019-2030)
8.2 Europe Dihydroartemisinin Sales Quantity by Application (2019-2030)
8.3 Europe Dihydroartemisinin Market Size by Country
8.3.1 Europe Dihydroartemisinin Sales Quantity by Country (2019-2030)
8.3.2 Europe Dihydroartemisinin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Dihydroartemisinin Market Size by Region
9.3.1 Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Dihydroartemisinin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Dihydroartemisinin Sales Quantity by Type (2019-2030)
10.2 South America Dihydroartemisinin Sales Quantity by Application (2019-2030)
10.3 South America Dihydroartemisinin Market Size by Country
10.3.1 South America Dihydroartemisinin Sales Quantity by Country (2019-2030)
10.3.2 South America Dihydroartemisinin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Dihydroartemisinin Market Size by Country
11.3.1 Middle East & Africa Dihydroartemisinin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Dihydroartemisinin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Dihydroartemisinin Market Drivers
12.2 Dihydroartemisinin Market Restraints
12.3 Dihydroartemisinin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dihydroartemisinin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dihydroartemisinin
13.3 Dihydroartemisinin Production Process
13.4 Dihydroartemisinin Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dihydroartemisinin Typical Distributors
14.3 Dihydroartemisinin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Dihydroartemisinin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dihydroartemisinin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pharmaceutical Grade
1.3.3 Industrial Grade
1.4 Market Analysis by Application
1.4.1 Overview: Global Dihydroartemisinin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Malaria Treatment
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Dihydroartemisinin Market Size & Forecast
1.5.1 Global Dihydroartemisinin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Dihydroartemisinin Sales Quantity (2019-2030)
1.5.3 Global Dihydroartemisinin Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dihydroartemisinin Product and Services
2.1.4 Sanofi Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 KPC Pharmaceuticals
2.2.1 KPC Pharmaceuticals Details
2.2.2 KPC Pharmaceuticals Major Business
2.2.3 KPC Pharmaceuticals Dihydroartemisinin Product and Services
2.2.4 KPC Pharmaceuticals Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 KPC Pharmaceuticals Recent Developments/Updates
2.3 Guangxi Xiancaotang Pharmaceutical
2.3.1 Guangxi Xiancaotang Pharmaceutical Details
2.3.2 Guangxi Xiancaotang Pharmaceutical Major Business
2.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product and Services
2.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
2.4 Guilin Pharmaceutical
2.4.1 Guilin Pharmaceutical Details
2.4.2 Guilin Pharmaceutical Major Business
2.4.3 Guilin Pharmaceutical Dihydroartemisinin Product and Services
2.4.4 Guilin Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Guilin Pharmaceutical Recent Developments/Updates
2.5 Kerui Nanhai Pharmaceutical
2.5.1 Kerui Nanhai Pharmaceutical Details
2.5.2 Kerui Nanhai Pharmaceutical Major Business
2.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product and Services
2.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates
2.6 Shanghai Natural Bio-engineering Co
2.6.1 Shanghai Natural Bio-engineering Co Details
2.6.2 Shanghai Natural Bio-engineering Co Major Business
2.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product and Services
2.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Shanghai Natural Bio-engineering Co Recent Developments/Updates
2.7 Novanat Bioresource
2.7.1 Novanat Bioresource Details
2.7.2 Novanat Bioresource Major Business
2.7.3 Novanat Bioresource Dihydroartemisinin Product and Services
2.7.4 Novanat Bioresource Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novanat Bioresource Recent Developments/Updates
2.8 Botanical Extracts EPZ Ltd
2.8.1 Botanical Extracts EPZ Ltd Details
2.8.2 Botanical Extracts EPZ Ltd Major Business
2.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Product and Services
2.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Botanical Extracts EPZ Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DIHYDROARTEMISININ BY MANUFACTURER
3.1 Global Dihydroartemisinin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Dihydroartemisinin Revenue by Manufacturer (2019-2024)
3.3 Global Dihydroartemisinin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Dihydroartemisinin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Dihydroartemisinin Manufacturer Market Share in 2023
3.4.2 Top 6 Dihydroartemisinin Manufacturer Market Share in 2023
3.5 Dihydroartemisinin Market: Overall Company Footprint Analysis
3.5.1 Dihydroartemisinin Market: Region Footprint
3.5.2 Dihydroartemisinin Market: Company Product Type Footprint
3.5.3 Dihydroartemisinin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dihydroartemisinin Market Size by Region
4.1.1 Global Dihydroartemisinin Sales Quantity by Region (2019-2030)
4.1.2 Global Dihydroartemisinin Consumption Value by Region (2019-2030)
4.1.3 Global Dihydroartemisinin Average Price by Region (2019-2030)
4.2 North America Dihydroartemisinin Consumption Value (2019-2030)
4.3 Europe Dihydroartemisinin Consumption Value (2019-2030)
4.4 Asia-Pacific Dihydroartemisinin Consumption Value (2019-2030)
4.5 South America Dihydroartemisinin Consumption Value (2019-2030)
4.6 Middle East and Africa Dihydroartemisinin Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Dihydroartemisinin Sales Quantity by Type (2019-2030)
5.2 Global Dihydroartemisinin Consumption Value by Type (2019-2030)
5.3 Global Dihydroartemisinin Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dihydroartemisinin Sales Quantity by Application (2019-2030)
6.2 Global Dihydroartemisinin Consumption Value by Application (2019-2030)
6.3 Global Dihydroartemisinin Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Dihydroartemisinin Sales Quantity by Type (2019-2030)
7.2 North America Dihydroartemisinin Sales Quantity by Application (2019-2030)
7.3 North America Dihydroartemisinin Market Size by Country
7.3.1 North America Dihydroartemisinin Sales Quantity by Country (2019-2030)
7.3.2 North America Dihydroartemisinin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Dihydroartemisinin Sales Quantity by Type (2019-2030)
8.2 Europe Dihydroartemisinin Sales Quantity by Application (2019-2030)
8.3 Europe Dihydroartemisinin Market Size by Country
8.3.1 Europe Dihydroartemisinin Sales Quantity by Country (2019-2030)
8.3.2 Europe Dihydroartemisinin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Dihydroartemisinin Market Size by Region
9.3.1 Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Dihydroartemisinin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Dihydroartemisinin Sales Quantity by Type (2019-2030)
10.2 South America Dihydroartemisinin Sales Quantity by Application (2019-2030)
10.3 South America Dihydroartemisinin Market Size by Country
10.3.1 South America Dihydroartemisinin Sales Quantity by Country (2019-2030)
10.3.2 South America Dihydroartemisinin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Dihydroartemisinin Market Size by Country
11.3.1 Middle East & Africa Dihydroartemisinin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Dihydroartemisinin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Dihydroartemisinin Market Drivers
12.2 Dihydroartemisinin Market Restraints
12.3 Dihydroartemisinin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dihydroartemisinin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dihydroartemisinin
13.3 Dihydroartemisinin Production Process
13.4 Dihydroartemisinin Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dihydroartemisinin Typical Distributors
14.3 Dihydroartemisinin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Dihydroartemisinin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Dihydroartemisinin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Dihydroartemisinin Product and Services
Table 6. Sanofi Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. KPC Pharmaceuticals Major Business
Table 10. KPC Pharmaceuticals Dihydroartemisinin Product and Services
Table 11. KPC Pharmaceuticals Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. KPC Pharmaceuticals Recent Developments/Updates
Table 13. Guangxi Xiancaotang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Guangxi Xiancaotang Pharmaceutical Major Business
Table 15. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product and Services
Table 16. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
Table 18. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Guilin Pharmaceutical Major Business
Table 20. Guilin Pharmaceutical Dihydroartemisinin Product and Services
Table 21. Guilin Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Guilin Pharmaceutical Recent Developments/Updates
Table 23. Kerui Nanhai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Kerui Nanhai Pharmaceutical Major Business
Table 25. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product and Services
Table 26. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kerui Nanhai Pharmaceutical Recent Developments/Updates
Table 28. Shanghai Natural Bio-engineering Co Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Natural Bio-engineering Co Major Business
Table 30. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product and Services
Table 31. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Shanghai Natural Bio-engineering Co Recent Developments/Updates
Table 33. Novanat Bioresource Basic Information, Manufacturing Base and Competitors
Table 34. Novanat Bioresource Major Business
Table 35. Novanat Bioresource Dihydroartemisinin Product and Services
Table 36. Novanat Bioresource Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Novanat Bioresource Recent Developments/Updates
Table 38. Botanical Extracts EPZ Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Botanical Extracts EPZ Ltd Major Business
Table 40. Botanical Extracts EPZ Ltd Dihydroartemisinin Product and Services
Table 41. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Botanical Extracts EPZ Ltd Recent Developments/Updates
Table 43. Global Dihydroartemisinin Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 44. Global Dihydroartemisinin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Dihydroartemisinin Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 46. Market Position of Manufacturers in Dihydroartemisinin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Dihydroartemisinin Production Site of Key Manufacturer
Table 48. Dihydroartemisinin Market: Company Product Type Footprint
Table 49. Dihydroartemisinin Market: Company Product Application Footprint
Table 50. Dihydroartemisinin New Market Entrants and Barriers to Market Entry
Table 51. Dihydroartemisinin Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 53. Global Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 54. Global Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Dihydroartemisinin Average Price by Region (2019-2024) & (USD/MT)
Table 57. Global Dihydroartemisinin Average Price by Region (2025-2030) & (USD/MT)
Table 58. Global Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 59. Global Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 60. Global Dihydroartemisinin Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Dihydroartemisinin Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Dihydroartemisinin Average Price by Type (2019-2024) & (USD/MT)
Table 63. Global Dihydroartemisinin Average Price by Type (2025-2030) & (USD/MT)
Table 64. Global Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 65. Global Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 66. Global Dihydroartemisinin Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Dihydroartemisinin Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Dihydroartemisinin Average Price by Application (2019-2024) & (USD/MT)
Table 69. Global Dihydroartemisinin Average Price by Application (2025-2030) & (USD/MT)
Table 70. North America Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 71. North America Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 72. North America Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 73. North America Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 74. North America Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 75. North America Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 76. North America Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Europe Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Europe Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 81. Europe Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 82. Europe Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 83. Europe Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 84. Europe Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 87. Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 88. Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 89. Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 90. Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 91. Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 92. Asia-Pacific Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 95. South America Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 96. South America Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 97. South America Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 98. South America Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 99. South America Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 100. South America Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 103. Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 104. Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 105. Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 106. Middle East & Africa Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 107. Middle East & Africa Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 108. Middle East & Africa Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Dihydroartemisinin Raw Material
Table 111. Key Manufacturers of Dihydroartemisinin Raw Materials
Table 112. Dihydroartemisinin Typical Distributors
Table 113. Dihydroartemisinin Typical Customers
Table 1. Global Dihydroartemisinin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Dihydroartemisinin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Dihydroartemisinin Product and Services
Table 6. Sanofi Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. KPC Pharmaceuticals Major Business
Table 10. KPC Pharmaceuticals Dihydroartemisinin Product and Services
Table 11. KPC Pharmaceuticals Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. KPC Pharmaceuticals Recent Developments/Updates
Table 13. Guangxi Xiancaotang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Guangxi Xiancaotang Pharmaceutical Major Business
Table 15. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product and Services
Table 16. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
Table 18. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Guilin Pharmaceutical Major Business
Table 20. Guilin Pharmaceutical Dihydroartemisinin Product and Services
Table 21. Guilin Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Guilin Pharmaceutical Recent Developments/Updates
Table 23. Kerui Nanhai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Kerui Nanhai Pharmaceutical Major Business
Table 25. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product and Services
Table 26. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kerui Nanhai Pharmaceutical Recent Developments/Updates
Table 28. Shanghai Natural Bio-engineering Co Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Natural Bio-engineering Co Major Business
Table 30. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product and Services
Table 31. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Shanghai Natural Bio-engineering Co Recent Developments/Updates
Table 33. Novanat Bioresource Basic Information, Manufacturing Base and Competitors
Table 34. Novanat Bioresource Major Business
Table 35. Novanat Bioresource Dihydroartemisinin Product and Services
Table 36. Novanat Bioresource Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Novanat Bioresource Recent Developments/Updates
Table 38. Botanical Extracts EPZ Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Botanical Extracts EPZ Ltd Major Business
Table 40. Botanical Extracts EPZ Ltd Dihydroartemisinin Product and Services
Table 41. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Botanical Extracts EPZ Ltd Recent Developments/Updates
Table 43. Global Dihydroartemisinin Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 44. Global Dihydroartemisinin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Dihydroartemisinin Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 46. Market Position of Manufacturers in Dihydroartemisinin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Dihydroartemisinin Production Site of Key Manufacturer
Table 48. Dihydroartemisinin Market: Company Product Type Footprint
Table 49. Dihydroartemisinin Market: Company Product Application Footprint
Table 50. Dihydroartemisinin New Market Entrants and Barriers to Market Entry
Table 51. Dihydroartemisinin Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 53. Global Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 54. Global Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Dihydroartemisinin Average Price by Region (2019-2024) & (USD/MT)
Table 57. Global Dihydroartemisinin Average Price by Region (2025-2030) & (USD/MT)
Table 58. Global Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 59. Global Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 60. Global Dihydroartemisinin Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Dihydroartemisinin Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Dihydroartemisinin Average Price by Type (2019-2024) & (USD/MT)
Table 63. Global Dihydroartemisinin Average Price by Type (2025-2030) & (USD/MT)
Table 64. Global Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 65. Global Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 66. Global Dihydroartemisinin Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Dihydroartemisinin Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Dihydroartemisinin Average Price by Application (2019-2024) & (USD/MT)
Table 69. Global Dihydroartemisinin Average Price by Application (2025-2030) & (USD/MT)
Table 70. North America Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 71. North America Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 72. North America Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 73. North America Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 74. North America Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 75. North America Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 76. North America Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Europe Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Europe Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 81. Europe Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 82. Europe Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 83. Europe Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 84. Europe Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 87. Asia-Pacific Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 88. Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 89. Asia-Pacific Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 90. Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 91. Asia-Pacific Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 92. Asia-Pacific Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 95. South America Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 96. South America Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 97. South America Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 98. South America Dihydroartemisinin Sales Quantity by Country (2019-2024) & (K MT)
Table 99. South America Dihydroartemisinin Sales Quantity by Country (2025-2030) & (K MT)
Table 100. South America Dihydroartemisinin Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Dihydroartemisinin Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2019-2024) & (K MT)
Table 103. Middle East & Africa Dihydroartemisinin Sales Quantity by Type (2025-2030) & (K MT)
Table 104. Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2019-2024) & (K MT)
Table 105. Middle East & Africa Dihydroartemisinin Sales Quantity by Application (2025-2030) & (K MT)
Table 106. Middle East & Africa Dihydroartemisinin Sales Quantity by Region (2019-2024) & (K MT)
Table 107. Middle East & Africa Dihydroartemisinin Sales Quantity by Region (2025-2030) & (K MT)
Table 108. Middle East & Africa Dihydroartemisinin Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Dihydroartemisinin Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Dihydroartemisinin Raw Material
Table 111. Key Manufacturers of Dihydroartemisinin Raw Materials
Table 112. Dihydroartemisinin Typical Distributors
Table 113. Dihydroartemisinin Typical Customers
LIST OF FIGURES
Figure 1. Dihydroartemisinin Picture
Figure 2. Global Dihydroartemisinin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Dihydroartemisinin Consumption Value Market Share by Type in 2023
Figure 4. Pharmaceutical Grade Examples
Figure 5. Industrial Grade Examples
Figure 6. Global Dihydroartemisinin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Dihydroartemisinin Consumption Value Market Share by Application in 2023
Figure 8. Malaria Treatment Examples
Figure 9. Scientific Research Examples
Figure 10. Others Examples
Figure 11. Global Dihydroartemisinin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Dihydroartemisinin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Dihydroartemisinin Sales Quantity (2019-2030) & (K MT)
Figure 14. Global Dihydroartemisinin Average Price (2019-2030) & (USD/MT)
Figure 15. Global Dihydroartemisinin Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Dihydroartemisinin Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Dihydroartemisinin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Dihydroartemisinin Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Dihydroartemisinin Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Dihydroartemisinin Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Dihydroartemisinin Average Price by Type (2019-2030) & (USD/MT)
Figure 30. Global Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Dihydroartemisinin Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Dihydroartemisinin Average Price by Application (2019-2030) & (USD/MT)
Figure 33. North America Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 53. China Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Dihydroartemisinin Market Drivers
Figure 74. Dihydroartemisinin Market Restraints
Figure 75. Dihydroartemisinin Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Dihydroartemisinin in 2023
Figure 78. Manufacturing Process Analysis of Dihydroartemisinin
Figure 79. Dihydroartemisinin Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Dihydroartemisinin Picture
Figure 2. Global Dihydroartemisinin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Dihydroartemisinin Consumption Value Market Share by Type in 2023
Figure 4. Pharmaceutical Grade Examples
Figure 5. Industrial Grade Examples
Figure 6. Global Dihydroartemisinin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Dihydroartemisinin Consumption Value Market Share by Application in 2023
Figure 8. Malaria Treatment Examples
Figure 9. Scientific Research Examples
Figure 10. Others Examples
Figure 11. Global Dihydroartemisinin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Dihydroartemisinin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Dihydroartemisinin Sales Quantity (2019-2030) & (K MT)
Figure 14. Global Dihydroartemisinin Average Price (2019-2030) & (USD/MT)
Figure 15. Global Dihydroartemisinin Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Dihydroartemisinin Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Dihydroartemisinin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Dihydroartemisinin Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Dihydroartemisinin Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Dihydroartemisinin Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Dihydroartemisinin Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Dihydroartemisinin Average Price by Type (2019-2030) & (USD/MT)
Figure 30. Global Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Dihydroartemisinin Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Dihydroartemisinin Average Price by Application (2019-2030) & (USD/MT)
Figure 33. North America Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 53. China Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Dihydroartemisinin Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Dihydroartemisinin Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Dihydroartemisinin Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Dihydroartemisinin Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Dihydroartemisinin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Dihydroartemisinin Market Drivers
Figure 74. Dihydroartemisinin Market Restraints
Figure 75. Dihydroartemisinin Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Dihydroartemisinin in 2023
Figure 78. Manufacturing Process Analysis of Dihydroartemisinin
Figure 79. Dihydroartemisinin Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
